| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 600080 | Colloids and Surfaces B: Biointerfaces | 2013 | 8 Pages |
•Chitosan/alginate multilayer film contained indomethacin is assembled as delivery system.•This drug delivery system exhibits controlled indomethacin release performance.•This multilayer film could eliminate the initial burst release of cupric ion.•This medicated device may be useful to diminish side effects existed in a Cu-IUD.
To reduce such side effects as pain and bleeding caused by copper-containing intrauterine device (Cu-IUD), a novel medicated intrauterine device, which is coated with an indomethacin (IDM) delivery system on the surface of copper/low-density polyethylene (Cu/LDPE) composite intrauterine device, has been proposed and developed in the present work. The IDM delivery system is a polyelectrolyte multilayer film, which is composed of IDM containing chitosan and alginate layer by layer, is prepared by using self-assembled polyelectrolyte multilayer method, and the number of the layers of this IDM containing chitosan/alginate multilayer film can be tailored by controlling the cyclic repetition of the deposition process. After the IDM containing chitosan/alginate multilayer film is obtained on the surface of Cu/LDPE composite intrauterine device, its release behavior of both IDM and cupric ion has been studied in vitro. The results show that the release duration of IDM increase with the increasing of thickness of the IDM containing chitosan/alginate multilayer film, and the initial burst release of cupric ion cannot be found in this novel medicated Cu/LDPE composite IUD. These results can be applied to guide the design of novel medicated Cu-IUD with minimal side effects for the future clinical use.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
